VASOPTIC MEDICAL, INC.

Baltimore, MD · Founded 2012 · Medtech · Private

Optical imaging system integrated with surgical microscope for real-time blood flow visualization during neurosurgery using laser speckle contrast imaging

Claim this profile

Follows are private to you and power your alerts

Updated · vasoptic.com

Sector
Medtech
Headquarters
Baltimore, MD
Founded
2012
Latest Form D
$1.6M, Apr 2017
Total capital
$12.9M
Federal grants
$11.1M
17 awards · 2015–2025
Rank in peer group#26 of 538
Private capital raised
$1.8M
3 Form D · last Apr 2017
115 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
6
10 pending · first 2016
Rank in peer group#97 of 538

Capital timeline

201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $12.9M$1.5M$1.5M$746K$1.6M$883K$875K2nd Form D$250K3rd Form D$1.6M
201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $12.9M$1.5M$1.5M$1.6M$883K3rd Form D$1.6M

Latest events

  • Federal grantHealth and Human S · Phase I · Imaging of Neurovascular Response for Assessment of Alzheimer's Disease$500K
  • Federal grantHealth and Human S · Phase II · Ocular Blood Flow Imaging for Glaucoma Assessment$246K
  • Federal grantHealth and Human S · Phase II · Ocular Blood Flow Imaging for Glaucoma Assessment$875K
  • Federal grantHealth and Human S · Phase II · Dye-free, on-demand visualization of blood flow during cerebrovascular surgery$883K
  • Federal grantHealth and Human S · Phase II · Ocular Blood Flow Imaging for Glaucoma Assessment$675K
  • Federal grantHealth and Human S · Phase II · Dye-free, on-demand visualization of blood flow during cerebrovascular surgery$1.6M
  • Federal grantHealth and Human S · Phase I · Assessment of episcleral vasculature for glaucoma management$257K
  • Private capital raisedForm D · SEC · 3rd filing$1.6M
  • Private capital raisedForm D · SEC · 2nd filing$250K
  • Private capital raisedForm D · SEC · 1st filing$11K
Show 10 earlier federal awards
  • Federal grantHealth and Human S · Phase I · Blood Flow Imaging for Minimally Invasive Surgeryhttps://apps.era.nih.gov/grantfolder/viewInternalGF.era?applId=10008550$256K
  • Federal grantHealth and Human S · Phase I · Development of Flow Based Biomarkers for Retinopathy of Prematurity - Supplemental Aim$96K
  • Federal grantHealth and Human S · Phase I · Development of Flow Based Biomarkers for Retinopathy of Prematurity - Supplemental Aim$389K
  • Federal grantHealth and Human S · Phase I · Development of Flow Based Biomarkers for Retinopathy of Prematurity$293K
  • Federal grantHealth and Human S · Phase II · Real Time Noninvasive Monitoring of Blood Flow During Surgery$742K
  • Federal grantHealth and Human S · Phase II · Laser Speckle Imaging Chip for Telehealth Applications$746K
  • Federal grantHealth and Human S · Phase II · Real Time Noninvasive Monitoring of Blood Flow During Surgery$1.5M
  • Federal grantHealth and Human S · Phase II · Laser Speckle Imaging Chip for Telehealth Applications$1.5M
  • Federal grantHealth and Human S · Phase I · Laser Speckle Imaging Chip for Telehealth Applications$340K
  • Federal grantHealth and Human S · Phase I · Real time and noninvasive monitoring of blood flow during surgery$249K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#26 · top 5%
  • Granted patents#97 · top 18%
  • Linked publications#55 · top 10%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Abhishek Jason RegeResearcherExecutive Officer, DirectorLinked by 6 patents · $11.1M in grants as PI
  • M. Jason BrookeExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 6 granted of 16
Show all 16 patent records

Recent research by its founders

  • Retinal Blood Flow Decreases After Treatment with Laser Photocoagulation for Retinopathy of Prematurity20260 cites
  • Retinal Blood Flow Decreases after Treatment with Bevacizumab for Retinopathy of Prematurity20251 cites
  • Realtime assessment of vascular occlusion and reperfusion in animal models of intraoperative imaging – a pilot study20241 cites
  • SENTIAR, INC.Similar federal contract value in Medtech · null in contracts
  • ZETAGEN THERAPEUTICS, INC.Similar federal contract value in Medtech · null in contracts
  • Harpoon Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • Nupulsecv IncSimilar federal contract value in Medtech · null in contracts
  • VADOVATIONS, INC.Similar federal contract value in Medtech · null in contracts
  • ABREOS BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .